Key result
Successful CTO-PCI linked to a ~60% reduction in MACE compared to failed procedures.
Why the study?
Does successful PCI-CTO reduce major adverse cardiovascular events in patients with coronary chronic total occlusion compared to failed PCI-CTO?
Cohort (n=283)
No
Does successful PCI-CTO reduce major adverse cardiovascular events in patients with coronary chronic total occlusion compared to failed PCI-CTO?
Hazard Ratio: 0.402 (95% CI 0.196–0.824)
Absolute Event Rate: 16.2% vs 37.9%
p-value: p=0.013
Successful recanalization of coronary chronic total occlusions is associated with significantly lower long-term rates of MACE and all-cause mortality compared to failed procedures.
Successful CTO PCI was associated with lower MACE and mortality; leaves open whether randomized trials will confirm benefit versus medical therapy.
The objective of the study was to evaluate major adverse cardiovascular events (MACE) after successful versus failed percutaneous coronary intervention for chronic total occlusion (PCI-CTO).Limited data are available on long-term clinical follow-up in the treatment of chronic total occlusion (CTO).Between January 2009 and December 2010 PCI-CTO was attempted in 283 consecutive patients with 289 CTO lesions. Procedural success was 62.3% and clinical follow-up covered 83% (235/283) of the study population with a median follow-up of 66 months (range, 59-74).The total incidence of MACE was 57/235 (24.3%), and was significantly higher in the procedural failure group than in the procedural success group (33/87 (37.9%) versus 24/148 (16.2%), P < 0.001). All-cause mortality was significantly lower in patients with successful PCI-CTO compared to failed PCI-CTO (10.8% versus 20.7%, P < 0.05). Also, the rate of cardiovascular death in the procedural failure group (14.9%) was slightly higher than that in the procedural success group (7.4%, P = 0.066). The rate of TVR was statistically higher in the procedural failure group (P < 0.009). Propensity score-adjusted Cox regression showed that procedural success remained a significant predictor of MACE (adjusted HR 0.402; 95% CI 0.196-0.824; P = 0.013).Our study emphasizes the importance of CTO recanalization in improving long-term outcome including all-cause mortality with a borderline effect on cardiovascular mortality.
No takes yet. Share an insight, caveat, or question.
Stojković et al. (2018) conducted a cohort in Coronary Chronic Total Occlusion (n=283). Successful PCI of CTO vs. Failed PCI of CTO was evaluated on Major adverse cardiovascular events (MACE) (HR 0.402, 95% CI 0.196-0.824, p=0.013). Successful percutaneous coronary intervention of chronic total occlusion significantly reduced the risk of major adverse cardiovascular events compared to failed procedures (adjusted HR 0.402).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: